Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01873677 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis
A Phase 3 study, sponsored by Maruho North America.
- Completed
- Registry status
- Phase 3
- Development phase
- 537
- Enrollment target
NCT01873677 is a Phase 3 study that has completed, run by Maruho North America. The registered enrollment target is 537 participants.
The verdict
NCT01873677, a Phase 3 study, has completed, sponsored by Maruho North America.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 537 participants
- Enrollment target
Study Summary
This study is to evaluate the efficacy and safety of M518101 in subjects with plaque psoriasis.
Interventions
- DRUG Vehicle
- DRUG M518101
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 537 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01873677
The ClinicalTrials.gov registry entry for NCT01873677 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 537 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maruho North America, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT01873677 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01873677 about?
NCT01873677 is a clinical study titled "Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis". This study is to evaluate the efficacy and safety of M518101 in subjects with plaque psoriasis.
What is the current status of trial NCT01873677?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 537 participants. The study started on 2013-06. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01873677?
The interventions under investigation include: Vehicle (DRUG), M518101 (DRUG).
Who is sponsoring clinical trial NCT01873677?
This trial is sponsored by Maruho North America, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.